Latest Belimumab Stories
ROCKVILLE, Md., July 30 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today announced financial results and key developments for the quarter ended June 30, 2008.
ROCKVILLE, Md., July 24 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today announced that David P. Southwell has been appointed to the HGS Board of Directors. He will also serve as a member of the Company's Audit Committee. Until recently, Mr.
BOSTON (Reuters) - Biotechnology company Human Genome Science Inc. said on Wednesday that it plans shortly to seek approval from U.S. regulators to run a late-stage clinical trial of its drug to treat systemic lupus erythematosus, a chronic, life-threatening disease. If the U.S.
ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc.
- A serpent whose bite was fabled to produce intense thirst.